Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells. Tidball AM, Neely MD, Chamberlin R, Aboud AA, Kumar KK, Han B, Bryan MR, Aschner M, Ess KC, Bowman AB (2016) PLoS One 11(3): e0150372
    › Primary publication · 26982737 (PubMed) · PMC4794230 (PubMed Central)
  2. Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. Brown JA, Pensabene V, Markov DA, Allwardt V, Neely MD, Shi M, Britt CM, Hoilett OS, Yang Q, Brewer BM, Samson PC, McCawley LJ, May JM, Webb DJ, Li D, Bowman AB, Reiserer RS, Wikswo JP (2015) Biomicrofluidics 9(5): 054124
    › Primary publication · 26576206 (PubMed) · PMC4627929 (PubMed Central)
  3. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes. Chun YW, Balikov DA, Feaster TK, Williams CH, Sheng CC, Lee JB, Boire TC, Neely MD, Bellan LM, Ess KC, Bowman AB, Sung HJ, Hong CC (2015) Biomaterials : 52-64
    › Primary publication · 26204225 (PubMed) · PMC4550551 (PubMed Central)
  4. A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease. Tidball AM, Bryan MR, Uhouse MA, Kumar KK, Aboud AA, Feist JE, Ess KC, Neely MD, Aschner M, Bowman AB (2015) Hum Mol Genet 24(7): 1929-44
    › Primary publication · 25489053 (PubMed) · PMC4355025 (PubMed Central)
  5. Cellular manganese content is developmentally regulated in human dopaminergic neurons. Kumar KK, Lowe EW, Aboud AA, Neely MD, Redha R, Bauer JA, Odak M, Weaver CD, Meiler J, Aschner M, Bowman AB (2014) Sci Rep : 6801
    › Primary publication · 25348053 (PubMed) · PMC4210885 (PubMed Central)
  6. PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper. Aboud AA, Tidball AM, Kumar KK, Neely MD, Han B, Ess KC, Hong CC, Erikson KM, Hedera P, Bowman AB (2015) Neurobiol Dis : 204-12
    › Primary publication · 25315681 (PubMed) · PMC4394022 (PubMed Central)
  7. Gammaretroviral vector encoding a fluorescent marker to facilitate detection of reprogrammed human fibroblasts during iPSC generation. Srinivasakumar N, Zaboikin M, Tidball AM, Aboud AA, Neely MD, Ess KC, Bowman AB, Schuening FG (2013) PeerJ : e224
    › Primary publication · 24392288 (PubMed) · PMC3869187 (PubMed Central)
  8. Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects. Aboud AA, Tidball AM, Kumar KK, Neely MD, Ess KC, Erikson KM, Bowman AB (2012) Neurotoxicology 33(6): 1443-9
    › Primary publication · 23099318 (PubMed) · PMC3518601 (PubMed Central)
  9. DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction. Neely MD, Litt MJ, Tidball AM, Li GG, Aboud AA, Hopkins CR, Chamberlin R, Hong CC, Ess KC, Bowman AB (2012) ACS Chem Neurosci 3(6): 482-91
    › Primary publication · 22860217 (PubMed) · PMC3400384 (PubMed Central)
  10. Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. Garcia BG, Neely MD, Deutch AY (2010) Cereb Cortex 20(10): 2423-32
    › Primary publication · 20118184 (PubMed) · PMC2936803 (PubMed Central)
  11. Combination of diOlistic labeling with retrograde tract tracing and immunohistochemistry. Neely MD, Stanwood GD, Deutch AY (2009) J Neurosci Methods 184(2): 332-6
    › Primary publication · 19712695 (PubMed) · PMC2796483 (PubMed Central)
  12. Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation. Nayyar T, Bubser M, Ferguson MC, Neely MD, Shawn Goodwin J, Montine TJ, Deutch AY, Ansah TA (2009) Eur J Neurosci 30(2): 207-16
    › Primary publication · 19659923 (PubMed) · PMC2765981 (PubMed Central)
  13. Localization of myocyte enhancer factor 2 in the rodent forebrain: regionally-specific cytoplasmic expression of MEF2A. Neely MD, Robert EM, Baucum AJ, Colbran RJ, Muly EC, Deutch AY (2009) Brain Res : 55-65
    › Primary publication · 19362076 (PubMed) · PMC2723059 (PubMed Central)
  14. Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neely MD, Schmidt DE, Deutch AY (2007) Neuroscience 149(2): 457-64
    › Primary publication · 17888581 (PubMed) · PMC2094700 (PubMed Central)
  15. Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration. Mathur BN, Neely MD, Dyllick-Brenzinger M, Tandon A, Deutch AY (2007) Brain Res : 83-9
    › Primary publication · 17706185 (PubMed) · PMC2040265 (PubMed Central)